Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma
Discover Oncology · 18.08.2025 · 16 (1)
DOI: 10.1007/s12672-025-03314-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 18.08.2025. Verfasst von Yue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shangh…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science foundation for Excellent Young Scholars of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor, notable for its high heterogeneity. Glycolysis plays a critical role in tumorigenesis, progression, and drug resistance across various malignancies, while the therapeutic implications of targeting glycolysis remain underexplored. This study aims to identify glycolysis-related molecular subtypes, explore their functional heterogeneity, and develop a prognostic model for iCCA. METHODS: Consensus clustering based on 121 glycolysis-related prognostic genes was performed to classify iCCA patients. Functional enrichment analyses revealed key biological pathways associated with tumor progression. A 9-gene risk model (ALDH1B1, DDIT4, GALE, HK1, HMMR, PGAM1, PGK1, PLOD1, SAP30) was constructed using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm and multivariate Cox regression analysis. HMMR, a glycolysis-related gene, was further investigated for its clinical significance. RESULTS: Two molecular subtypes with distinct survival outcomes (p < 0.001) were identified. Functional analyses further revealed that upregulated genes in the C1 subtype were enriched in hypoxia, TNF-α signaling via NF-κB, p53, and apoptosis pathways. A risk model effectively stratified patients into high- and low-risk groups, with worse survival in the high-risk group (p < 0.001, AUC = 0.76 for 1-year, 0.80 for 3-year). A nomogram incorporating the risk score and clinical factors (γ-GT, vascular invasion, lymph node metastasis) achieved a C-index of 0.793. Finally, we identified HMMR as a candidate prognostic biomarker for iCCA patients. Moreover, HMMR was overexpressed in iCCA and associated with poor prognosis, while its knockdown significantly reduced tumor cell proliferation, migration, and invasion (p < 0.001). CONCLUSIONS: The glycolysis-based risk model enables precise patient stratification and may facilitate clinical decision-making, while HMMR represents a promising therapeutic target, offering novel insights into iCCA prognosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China.
- Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
- Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
- Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fu.xiutao@zs-hospital.sh.cn.
- Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China. fu.xiutao@zs-hospital.sh.cn.
Förderung
- the National Natural Science foundation for Excellent Young Scholars of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Wang, P., Liu, H., Feng, H., Cao, M., Zhang, Z., Rao, K., Fan, J., Fu, X., & Sun, Y. (2025). Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03314-4
Vancouver
Wang Y, Wang P, Liu H, Feng H, Cao M, Zhang Z, et al. Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03314-4
BibTeX
@article{Wang2025,
author = {Wang, Yue and Wang, Pengxiang and Liu, Hui and Feng, Haokang and Cao, Muzi and Zhang, Zefan and Rao, Keqiang and Fan, Jia and Fu, Xiutao and Sun, Yunfan},
title = {Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma},
journal = {Discover Oncology},
year = {2025},
volume = {16},
number = {1},
doi = {10.1007/s12672-025-03314-4}
}
EUVIMED